je.st
news
European Commission approves EYLEA Injection for treatment of visual impairment due to DME
2014-08-11 12:16:33| Biotech - Topix.net
Regeneron Pharmaceuticals, Inc. today announced that EYLEA Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema .
Tags: to
due
treatment
visual
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||